Assertio Holdings Croissance future

Future contrôle des critères 3/6

Assertio Holdings devrait augmenter ses bénéfices et son chiffre d'affaires de 81.3% et de 4.4% par an respectivement. Le BPA devrait croître de de 81.6% par an. Le rendement des capitaux propres devrait être 14.1% dans 3 ans.

Informations clés

81.3%

Taux de croissance des bénéfices

81.6%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices	23.9%
Taux de croissance des recettes	4.4%
Rendement futur des capitaux propres	14.1%
Couverture par les analystes	Low
Dernière mise à jour	25 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding

Nov 15

Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?

Sep 25

Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%

Aug 19

There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise

Jul 04

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 07

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Apr 18

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Mar 13

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Apr 26

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Mar 02

Prévisions de croissance des bénéfices et des revenus

NasdaqCM:ASRT - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	139	15	35	36	2
12/31/2025	124	-6	22	29	5
12/31/2024	121	-15	16	17	5
9/30/2024	126	-68	20	21	N/A
6/30/2024	132	-345	23	23	N/A
3/31/2024	142	-333	33	34	N/A
12/31/2023	152	-332	49	50	N/A
9/30/2023	169	-186	44	71	N/A
6/30/2023	168	98	51	78	N/A
3/31/2023	162	97	32	74	N/A
12/31/2022	156	110	36	79	N/A
9/30/2022	139	26	21	56	N/A
6/30/2022	130	25	16	51	N/A
3/31/2022	121	3	18	37	N/A
12/31/2021	111	-1	-13	6	N/A
9/30/2021	110	-30	-5	-5	N/A
6/30/2021	119	-44	-24	-24	N/A
3/31/2021	114	-65	-44	-45	N/A
12/31/2020	108	-28	303	-66	N/A
9/30/2020	135	-196	317	-52	N/A
6/30/2020	156	-183	365	-3	N/A
3/31/2020	192	-162	405	38	N/A
12/31/2019	230	-217	89	90	N/A
9/30/2019	157	-49	95	98	N/A
6/30/2019	180	-4	130	135	N/A
3/31/2019	186	-11	121	127	N/A
12/31/2018	256	37	67	72	N/A
9/30/2018	364	28	80	84	N/A
6/30/2018	381	-36	N/A	10	N/A
3/31/2018	419	-42	N/A	19	N/A
12/31/2017	381	-102	N/A	62	N/A
9/30/2017	410	-114	N/A	76	N/A
6/30/2017	425	-111	N/A	96	N/A
3/31/2017	442	-95	N/A	103	N/A
12/31/2016	456	-89	N/A	71	N/A
9/30/2016	443	-75	N/A	88	N/A
6/30/2016	437	-74	N/A	120	N/A
3/31/2016	415	-85	N/A	130	N/A
12/31/2015	343	-76	N/A	152	N/A
9/30/2015	426	50	N/A	89	N/A
6/30/2015	373	68	N/A	40	N/A
3/31/2015	346	102	N/A	7	N/A
12/31/2014	390	132	N/A	-56	N/A
9/30/2014	236	79	N/A	-60	N/A
6/30/2014	222	79	N/A	-45	N/A
3/31/2014	185	67	N/A	-51	N/A
12/31/2013	134	43	N/A	10	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: ASRT devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 2.6% ).

Bénéfices vs marché: ASRT devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: ASRT devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de ASRT ( 4.4% par an) devrait croître plus lentement que le marché de US ( 8.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de ASRT ( 4.4% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de ASRT devrait être faible dans 3 ans ( 14.1 %).

Assertio Holdings Croissance future

Future contrôle des critères 3/6

Informations clés

Mises à jour récentes de la croissance future

Consensus EPS estimates fall by 20%

Assertio Holdings, Inc. Reiterates Earnings Guidance for the Year 2024

Consensus revenue estimates fall by 27%

Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024

Consensus EPS estimates fall by 18%

Consensus revenue estimates increase by 13%, EPS downgraded

Recent updates

Independent Chairman recently bought US$60k worth of stock

New minor risk - Share price stability

Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Assertio Holdings, Inc. Announces Board Changes

Assertio Holdings, Inc. to Report Q3, 2024 Results on Nov 11, 2024

New minor risk - Market cap size

Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?

Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%

Consensus EPS estimates fall by 20%

New minor risk - Profitability

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings

There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise

Assertio Holdings, Inc. Announces the Appointment of Brendan P. O’Grady as CEO

The Buxton Helmsley Group Sends Letter to Assertio Holdings

The Buxton Helmsley Group Sends Letter to Assertio Holdings

Assertio Holdings, Inc. Reiterates Earnings Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Assertio Holdings, Inc. to Report Q1, 2024 Results on May 06, 2024

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Assertio Holdings, Inc., Annual General Meeting, May 23, 2024

Consensus revenue estimates fall by 27%

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Full year 2023 earnings: EPS misses analyst expectations

Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024

Assertio Holdings, Inc. to Report Q4, 2023 Results on Mar 11, 2024

New major risk - Share price stability

Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors

Bragar Eagel & Squire, P.C. Announces Class Action Lawsuit Against Assertio Holdings, Inc

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

New minor risk - Market cap size

Assertio Holdings, Inc. Announces CFO Changes

New minor risk - Profitability

Consensus EPS estimates fall by 18%

Assertio Holdings, Inc. to Report Q3, 2023 Results on Nov 08, 2023

President recently sold US$479k worth of stock

President notifies of intention to sell stock

New major risk - Shareholder dilution

Independent Director notifies of intention to sell stock

New minor risk - Share price stability

Assertio Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $25 million.

Consensus revenue estimates increase by 13%, EPS downgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023

Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).

Assertio Holdings, Inc. Appoints Jeffrey Vacirca to Its Board of Directors

Assertio Holdings, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Independent Director recently sold US$652k worth of stock

President exercised options and sold US$2.9m worth of stock

Consensus EPS estimates fall by 30%, revenue upgraded

Assertio Holdings, Inc. Raises Earnings Guidance for the Full Year of 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Director notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 17%

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued

Price target increased by 9.6% to US$7.88

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Investor sentiment improves as stock rises 18%

Consensus EPS estimates increase by 164%

President exercised options and sold US$257k worth of stock

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 11%

Investor sentiment deteriorated over the past week